Samantha J Riesenfeld

Title: Innovations and Contributions of Samantha J Riesenfeld

Introduction

Samantha J Riesenfeld is a prominent inventor based in Cambridge, MA. She has made significant contributions to the field of immunology, particularly in understanding and modulating innate lymphoid cells (ILCs). With a total of two patents to her name, her work has implications for treating various inflammatory conditions.

Latest Patents

Riesenfeld's latest patents include "Methods and compositions for modulating innate lymphoid cell pathogenic effectors" and "Methods and compositions for regulating innate lymphoid cell inflammatory responses." The first patent focuses on methods and compositions aimed at modulating inflammation driven by the differentiation of quiescent tissue-resident ILCs into pathogenic effectors. This work is crucial for detecting and monitoring ILC responses and treating skin inflammation, such as psoriasis. The second patent highlights the role of the neuropeptide receptor Nmur1 in Type 2 innate lymphoid cells (ILC2s). It reveals how Nmur1 signaling modulates IL-25-mediated ILC2 responses, emphasizing the importance of neuro-immune crosstalk in allergic inflammatory responses.

Career Highlights

Throughout her career, Riesenfeld has worked with esteemed institutions such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. Her research has significantly advanced the understanding of ILCs and their role in inflammation.

Collaborations

Some of her notable coworkers include Monika S Kowalczyk and Aviv Regev. Their collaborative efforts have contributed to the success of her research projects.

Conclusion

Samantha J Riesenfeld's innovative work in the field of immunology has led to important advancements in understanding and treating inflammatory conditions. Her patents reflect her commitment to improving health outcomes through scientific research.